This white paper will examine the use of sputum induction as a pharmacodynamic method to optimize respiratory patient clinical trials, including comparison to other methods, and a case study looking at asthma patients and healthy volunteers.
Units 303 & 305, 3/F, Building 22E,
Phase 3, Hong Kong Science Park,
Pak Shek Kok, New Territories, Hong Kong, China